In addition, one study reported that NEDD4L level was higher in prostate cancer tissues than in adjacent normal tissues, and NEDD4L might contribute to the development of prostate cancer by inhibiting the TGF-β signaling pathway (Hellwinkel et al., 2011). Here, NEDD4L is linked to prostate carcinoma.